The editor of the British Medical Journal has actually asked the New York Times to correct a short article that says UK standards enable two Covid-19 vaccines to be blended.
The US publication reported that UK health officials would permit clients to be provided a second dosage that is a various vaccine to their very first.
Fiona Godlee explained in her letter to the NYT that it was not a suggestion.
She stated the NYT’s heading declaring UK standards state such replacements “may occur” was “seriously misleading”.
The UK has actually approved the Pfizer-BioNTech vaccine and the Oxford-AstraZeneca jab – but both require 2 doses which are now to be administered 12 weeks apart
Ms Godlee stated the Joint Committee on Vaccination and Immunisation (JCVI) does not make any suggestion to mix and match – in other words, having a shot of one vaccine and then a different one 12 weeks later.
Dr Mary Ramsay, Public Health England’s head of immunisations, stated: “We do not suggest blending the Covid-19 vaccines – if your first dose is the Pfizer vaccine you ought to not be given the AstraZeneca vaccine for your second dosage and vice versa.”
Dr Ramsay included that on the “extremely rare occasions” where the very same vaccine is unavailable or it is unidentified which jab the client received, it is “much better to give a second dose of another vaccine than not”.
Ms Godlee prompted the New York Times to print a “extremely noticeable correction” as soon as possible.
On the other hand, health personnel have actually criticised the documentation needed to acquire NHS approval to offer the coronavirus vaccine, with some medics being asked for proof they are trained in locations such as preventing radicalisation.
The first dosages of the Oxford-AstraZeneca vaccine are because of be provided on Monday after the jab was approved for usage in the UK recently.
The Pfizer-BioNTech vaccine was the first vaccine authorized in the UK, and 944,539 people have had their first jab.